Vaxart, Inc.
VXRT
$0.4945
-$0.038-7.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 433.43% | 288.94% | 303.27% | 577.76% | 1,174.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 433.43% | 288.94% | 303.27% | 577.76% | 1,174.75% |
| Cost of Revenue | 27.26% | 8.91% | -10.33% | -18.63% | -18.12% |
| Gross Profit | 34.27% | 25.10% | 29.02% | 34.09% | 28.28% |
| SG&A Expenses | -19.78% | -7.99% | -5.91% | -11.14% | -20.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.24% | 4.70% | -9.26% | -16.84% | -18.87% |
| Operating Income | 30.16% | 20.46% | 23.18% | 28.48% | 26.35% |
| Income Before Tax | 29.03% | 18.87% | 18.92% | 25.25% | 24.37% |
| Income Tax Expenses | 11.91% | -0.38% | 150.49% | 248.75% | 264.47% |
| Earnings from Continuing Operations | 28.90% | 18.82% | 18.73% | 25.03% | 24.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.90% | 18.82% | 18.73% | 25.03% | 24.17% |
| EBIT | 30.16% | 20.46% | 23.18% | 28.48% | 26.35% |
| EBITDA | 34.02% | 23.13% | 26.30% | 31.87% | 29.97% |
| EPS Basic | 49.90% | 40.40% | 35.04% | 38.07% | 34.68% |
| Normalized Basic EPS | 50.01% | 40.47% | 37.27% | 39.92% | 36.43% |
| EPS Diluted | 49.73% | 40.25% | 34.90% | 37.96% | 34.68% |
| Normalized Diluted EPS | 50.01% | 40.47% | 37.27% | 39.92% | 36.43% |
| Average Basic Shares Outstanding | 44.06% | 42.18% | 29.43% | 21.39% | 15.79% |
| Average Diluted Shares Outstanding | 44.06% | 42.18% | 29.43% | 21.39% | 15.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |